Related Experiment Video
Updated: Sep 11, 2025

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Investigation of the Partial Volume Effect in Pre-Dosimetry of Liver Tumors for 90Y Radioembolization: A Phantom
Ayşe Dilaver Akar1, Nami Yeyin2, Sinem Akyol2
1İstanbul Aydın University, Graduate Education Institute, Health Physics Program, İstanbul, Türkiye.
Objectives:
Yttrium-90 (90Y) radioembolization has become increasingly important in the treatment of liver tumors. This study aims to experimentally determine the extent to which small liver tumors are affected by the partial volume effect (PVE) in single photon emission computed tomography/computed tomography (SPECT/CT) scintigraphy using technetium-99m-macroaggregated albumin (Tc-99m-MAA), and to investigate the impact of PVE on tumor dosimetry and image quality.
Methods:
In this experimental study, a custom-designed liver phantom containing four tumor mimics with diameters of 1 cm, 2 cm, 3 cm, and 5 cm was used. The tumor and liver parenchyma volumes were filled with Tc-99m at a ratio of 4.86: 1. The phantom was imaged in a water tank using SPECT/CT according to standard clinical protocols. Volumetric regions of interest were drawn for each lesion and tumor volumes, contrast values (C), contrast to noise ratios (CNR), and absorbed tumor doses were calculated from the counts obtained. Since this study does not involve live subjects and was conducted solely on a phantom model, ethical approval, informed consent, and consent forms are not required for this study.
Results:
Tumor diameters measured on SPECT/CT images matched those obtained from both CT images and the actual dimensions. The contrast values calculated from the SPECT/CT images for lesions with diameters of 2 cm and 5 cm were 2.03 and 3.89, respectively. Similarly, the corresponding CNR values were 8.64 and 21.07. Tumor-to-normal tissue ratios were 2.03 and 3.89 for the 2 cm and 5 cm lesions, respectively. For the 2 cm lesion, the actual and SPECT/CT-derived absorbed doses were 15.3 Gy and 7.87 Gy, respectively. For the 5 cm lesion, these values were 15.4 Gy and 13.38 Gy, respectively. The absorbed tumor doses significantly decreased as tumor diameter decreased due to the influence of PVE.
Conclusion:
Tumors smaller than 2 cm in diameter were markedly affected by the PVE. Considering the influence of PVE, or applying appropriate corrections in dosimetric calculations, is of critical importance for improving the accuracy of dosimetry results.
More Related Videos
08:54Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
09:49A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy PRRT: 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
Published on: April 24, 2020